Annals of Oncology Advance Access published online on May 13, 2005
Annals of Oncology, doi:10.1093/annonc/mdi255
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Division of Medical Oncology, Department of Medicine, European Institute of Oncology, Milan, Italy
* To whom correspondence should be addressed.
Editorial
Treatment of advanced breast cancer: the good, the bad and the ugly
2 Department of Adult Oncology, Dana-Farber Cancer Institute, Boston, MA, USA Statistical Center, International Breast Cancer Study Group, Boston, MA, USA
M. Colleoni, E-mail: marco.colleoni{at}ieo.it
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
D. Tassinari, B. Poggi, M. Fantini, E. Tamburini, S. Nicoletti, and S. Sartori Cost-opportunity analysis in clinical oncology: from the 'wild far-west' to a correct integration of the disciplines, avoiding the 'war of the worlds' Ann. Onc., May 1, 2006; 17(5): 876 - 877. [Full Text] [PDF] |
||||
